TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs213230
log Bayes Factor = 76.3996
Chromosome 6   position 28,330,264  (GRCh37) Explore rs213230 on Ensembl!

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
E05.9 Thyrotoxicosis, unspecified
1.000 0.000 0.000
K90.0 Coeliac disease
1.000 0.000 0.000
E05 Thyrotoxicosis [hyperthyroidism]
1.000 0.000 0.000
E00-E07 Disorders of thyroid gland
1.000 0.000 0.000
Chapter IV Endocrine, nutritional and metabolic diseases
1.000 0.000 0.000
E10 Insulin-dependent diabetes mellitus
1.000 0.000 0.000
E10-E14 Diabetes mellitus
1.000 0.000 0.000
E83.1 Disorders of iron metabolism
0.000 0.000 1.000
E03 Other hypothyroidism
1.000 0.000 0.000
E03.9 Hypothyroidism, unspecified
0.999 0.001 0.000
E10.9 Without complications
0.998 0.002 0.000
E15-E16 Other disorders of glucose regulation and pancreatic internal secretion
0.997 0.003 0.000
E20-E35 Disorders of other endocrine glands
0.996 0.004 0.000
E16 Other disorders of pancreatic internal secretion
0.994 0.006 0.000
E16.2 Hypoglycaemia, unspecified
0.993 0.007 0.000
E27 Other disorders of adrenal gland
0.985 0.015 0.000
E27.1 Primary adrenocortical insufficiency
0.980 0.020 0.000
E05.0 Thyrotoxicosis with diffuse goitre
0.979 0.021 0.000
E10.3 With ophthalmic complications
0.977 0.023 0.000
E14 Unspecified diabetes mellitus
0.958 0.042 0.000
E14.3 With ophthalmic complications
0.933 0.067 0.000
C15-C26 Malignant neoplasms of digestive organs
0.904 0.096 0.000
C19 Malignant neoplasm of rectosigmoid junction
0.903 0.097 0.000
C25 Malignant neoplasm of pancreas
0.898 0.102 0.000
E29 Testicular dysfunction
0.896 0.104 0.000
E10.1 With ketoacidosis
0.893 0.107 0.000
E10.2 With renal complications
0.892 0.108 0.000
C15 Malignant neoplasm of oesophagus
0.885 0.115 0.000
C25.9 Pancreas, unspecified
0.882 0.118 0.000
E13 Other specified diabetes mellitus
0.882 0.118 0.000
C22 Malignant neoplasm of liver and intrahepatic bile ducts
0.871 0.129 0.000
E10.4 With neurological complications
0.865 0.135 0.000
E20 Hypoparathyroidism
0.845 0.155 0.000
E03.2 Hypothyroidism due to medicaments and other exogenous substances
0.830 0.170 0.000
C15.4 Middle third of oesophagus
0.828 0.172 0.000
E29.1 Testicular hypofunction
0.824 0.176 0.000
C22.1 Intrahepatic bile duct carcinoma
0.820 0.180 0.000
C15.9 Oesophagus, unspecified
0.817 0.183 0.000
E34 Other endocrine disorders
0.812 0.188 0.000
E05.8 Other thyrotoxicosis
0.812 0.188 0.000
E13.9 Without complications
0.788 0.212 0.000
E10.0 With coma
0.787 0.213 0.000
E25 Adrenogenital disorders
0.777 0.223 0.000
E14.5 With peripheral circulatory complications
0.770 0.230 0.000
E27.9 Disorder of adrenal gland, unspecified
0.764 0.236 0.000
E27.4 Other and unspecified adrenocortical insufficiency
0.758 0.242 0.000
E24 Cushing's syndrome
0.757 0.243 0.000
E31 Polyglandular dysfunction
0.756 0.244 0.000
E23 Hypofunction and other disorders of pituitary gland
0.755 0.245 0.000
E16.0 Drug-induced hypoglycaemia without coma
0.755 0.245 0.000
E03.0 Congenital hypothyroidism with diffuse goitre
0.754 0.246 0.000
C25.3 Pancreatic duct
0.754 0.246 0.000
C22.9 Liver, unspecified
0.751 0.249 0.000
E20.9 Hypoparathyroidism, unspecified
0.738 0.262 0.000
E34.9 Endocrine disorder, unspecified
0.734 0.266 0.000
E14.4 With neurological complications
0.733 0.267 0.000
E83 Disorders of mineral metabolism
0.018 0.274 0.708
E10.7 With multiple complications
0.725 0.275 0.000
E10.5 With peripheral circulatory complications
0.722 0.278 0.000
E40-E46 Malnutrition
0.721 0.279 0.000
E05.5 Thyroid crisis or storm
0.717 0.283 0.000
E05.4 Thyrotoxicosis factitia
0.717 0.283 0.000
E05.3 Thyrotoxicosis from ectopic thyroid tissue
0.717 0.283 0.000
E05.1 Thyrotoxicosis with toxic single thyroid nodule
0.717 0.283 0.000
E01 Iodine-deficiency-related thyroid disorders and allied conditions
0.717 0.283 0.000
E00 Congenital iodine-deficiency syndrome
0.717 0.283 0.000
E12 Malnutrition-related diabetes mellitus
0.717 0.283 0.000
E03.5 Myxoedema coma
0.717 0.283 0.000
E03.4 Atrophy of thyroid (acquired)
0.717 0.283 0.000
E03.3 Postinfectious hypothyroidism
0.717 0.283 0.000
C25.8 Overlapping lesion of pancreas
0.716 0.284 0.000
E15 Nondiabetic hypoglycaemic coma
0.714 0.285 0.000
E35 Disorders of endocrine glands in diseases classified elsewhere
0.714 0.286 0.000
E32 Diseases of thymus
0.714 0.286 0.000
E30 Disorders of puberty, not elsewhere classified
0.714 0.286 0.000
E16.9 Disorder of pancreatic internal secretion, unspecified
0.713 0.287 0.000
E16.8 Other specified disorders of pancreatic internal secretion
0.713 0.287 0.000
E16.4 Abnormal secretion of gastrin
0.713 0.287 0.000
E16.3 Increased secretion of glucagon
0.713 0.287 0.000
E27.5 Adrenomedullary hyperfunction
0.706 0.294 0.000
E27.0 Other adrenocortical overactivity
0.706 0.294 0.000
C20 Malignant neoplasm of rectum
0.703 0.297 0.000
E16.1 Other hypoglycaemia
0.701 0.299 0.000
E14.6 With other specified complications
0.701 0.299 0.000
E27.3 Drug-induced adrenocortical insufficiency
0.701 0.299 0.000
E14.1 With ketoacidosis
0.697 0.303 0.000
C15.1 Thoracic part of oesophagus
0.696 0.304 0.000
E83.3 Disorders of phosphorus metabolism
0.002 0.305 0.693
E03.1 Congenital hypothyroidism without goitre
0.695 0.305 0.000
C25.2 Tail of pancreas
0.692 0.308 0.000
C25.4 Endocrine pancreas
0.689 0.311 0.000
C15.0 Cervical part of oesophagus
0.688 0.312 0.000
E14.7 With multiple complications
0.687 0.313 0.000
E14.0 With coma
0.687 0.313 0.000
E21 Hyperparathyroidism and other disorders of parathyroid gland
0.685 0.315 0.000
E27.2 Addisonian crisis
0.684 0.316 0.000
C17 Malignant neoplasm of small intestine
0.676 0.324 0.000
E10.6 With other specified complications
0.673 0.327 0.000
E14.2 Withrenal complications
0.671 0.329 0.000
C23 Malignant neoplasm of gallbladder
0.656 0.344 0.000
E13.3 With ophthalmic complications
0.655 0.345 0.000
C25.0 Head of pancreas
0.642 0.358 0.000
E29.9 Testicular dysfunction, unspecified
0.642 0.358 0.000
E29.8 Other testicular dysfunction
0.642 0.358 0.000
E29.0 Testicular hyperfunction
0.642 0.358 0.000
R31 Unspecified haematuria
0.000 0.359 0.641
C15.8 Overlapping lesion of oesophagus
0.634 0.366 0.000
C15.2 Abdominal part of oesophagus
0.634 0.366 0.000
C22.0 Liver cell carcinoma
0.633 0.367 0.000
E13.8 With unspecified complications
0.632 0.368 0.000
E13.7 With multiple complications
0.632 0.368 0.000
E13.6 With other specified complications
0.632 0.368 0.000
E13.5 With peripheral circulatory complications
0.632 0.368 0.000
E13.4 With neurological complications
0.632 0.368 0.000
E13.2 With renal complications
0.632 0.368 0.000
E13.1 With ketoacidosis
0.632 0.368 0.000
E13.0 With coma
0.632 0.368 0.000
C25.1 Body of pancreas
0.631 0.369 0.000
C17.0 Duodenum
0.627 0.373 0.000
C25.7 Other parts of pancreas
0.626 0.373 0.000
C22.7 Other specified carcinomas of liver
0.624 0.376 0.000
C22.4 Other sarcomas of liver
0.624 0.376 0.000
C22.3 Angiosarcoma of liver
0.624 0.376 0.000
C22.2 Hepatoblastoma
0.624 0.376 0.000
C24 Malignant neoplasm of other and unspecified parts of biliary tract
0.621 0.379 0.000
E25.0 Congenital adrenogenital disorders associated with enzyme deficiency
0.620 0.380 0.000
C16 Malignant neoplasm of stomach
0.611 0.389 0.000
E24.0 Pituitary-dependent Cushing's disease
0.610 0.390 0.000
E20.8 Other hypoparathyroidism
0.606 0.394 0.000
E20.1 Pseudohypoparathyroidism
0.606 0.394 0.000
E20.0 Idiopathic hypoparathyroidism
0.606 0.394 0.000
E21.3 Hyperparathyroidism, unspecified
0.604 0.396 0.000
C15.3 Upper third of oesophagus
0.604 0.396 0.000
E14.8 With unspecified complications
0.595 0.404 0.000
E23.7 Disorder of pituitary gland, unspecified
0.591 0.409 0.000
E23.2 Diabetes insipidus
0.590 0.410 0.000
E31.0 Autoimmune polyglandular failure
0.584 0.416 0.000
E28 Ovarian dysfunction
0.583 0.417 0.000
E34.5 Androgen resistance syndrome
0.582 0.418 0.000
E34.4 Constitutional tall stature
0.582 0.418 0.000
E34.3 Short stature, not elsewhere classified
0.582 0.418 0.000
E34.2 Ectopic hormone secretion, not elsewhere classified
0.582 0.418 0.000
E34.1 Other hypersecretion of intestinal hormones
0.582 0.418 0.000
K90 Intestinal malabsorption
0.581 0.419 0.000
E24.2 Drug-induced Cushing's syndrome
0.580 0.420 0.000
E02 Subclinical iodine-deficiency hypothyroidism
0.578 0.421 0.000
E07 Other disorders of thyroid
0.572 0.428 0.000
E25.9 Adrenogenital disorder, unspecified
0.557 0.443 0.000
E25.8 Other adrenogenital disorders
0.557 0.443 0.000
E24.8 Other Cushing's syndrome
0.556 0.444 0.000
E23.6 Other disorders of pituitary gland
0.554 0.446 0.000
E24.4 Alcohol-induced pseudo-Cushing's syndrome
0.543 0.457 0.000
E24.3 Ectopic ACTH syndrome
0.543 0.457 0.000
E24.1 Nelson's syndrome
0.543 0.457 0.000
E31.9 Polyglandular dysfunction, unspecified
0.542 0.458 0.000
E31.8 Other polyglandular dysfunction
0.542 0.458 0.000
E31.1 Polyglandular hyperfunction
0.542 0.458 0.000
E23.3 Hypothalamic dysfunction, not elsewhere classified
0.541 0.458 0.000
E23.1 Drug-induced hypopituitarism
0.541 0.458 0.000
C15.5 Lower third of oesophagus
0.538 0.462 0.000
C16.5 Lesser curvature of stomach, unspecified
0.537 0.463 0.000
E10.8 With unspecified complications
0.535 0.465 0.000
E34.8 Other specified endocrine disorders
0.525 0.475 0.000
E26 Hyperaldosteronism
0.524 0.475 0.001
E14.9 Without complications
0.521 0.479 0.000
E46 Unspecified protein-energy malnutrition
0.521 0.479 0.000
E83.9 Disorder of mineral metabolism, unspecified
0.013 0.480 0.508
E83.8 Other disorders of mineral metabolism
0.013 0.480 0.508
E83.2 Disorders of zinc metabolism
0.013 0.480 0.508
E83.0 Disorders of copper metabolism
0.013 0.480 0.508
E44 Protein-energy malnutrition of moderate and mild degree
0.517 0.483 0.000
E45 Retarded development following protein-energy malnutrition
0.517 0.483 0.000
E43 Unspecified severe protein-energy malnutrition
0.517 0.483 0.000
E42 Marasmic kwashiorkor
0.517 0.483 0.000
E41 Nutritional marasmus
0.517 0.483 0.000
E40 Kwashiorkor
0.517 0.483 0.000
E00.9 Congenital iodine-deficiency syndrome, unspecified
0.514 0.486 0.000
E00.2 Congenital iodine-deficiency syndrome, mixed type
0.514 0.486 0.000
E00.1 Congenital iodine-deficiency syndrome, myxoedematous type
0.514 0.486 0.000
E00.0 Congenital iodine-deficiency syndrome, neurological type
0.514 0.486 0.000
E01.8 Other iodine-deficiency-related thyroid disorders and allied conditions
0.514 0.486 0.000
E01.2 Iodine-deficiency-related (endemic) goitre, unspecified
0.514 0.486 0.000
E01.1 Iodine-deficiency-related multinodular (endemic) goitre
0.514 0.486 0.000
E01.0 Iodine-deficiency-related diffuse (endemic) goitre
0.514 0.486 0.000
E12.9 Without complications
0.514 0.486 0.000
E12.8 With unspecified complications
0.514 0.486 0.000
E12.7 With multiple complications
0.514 0.486 0.000
E12.6 With other specified complications
0.514 0.486 0.000
E12.5 With peripheral circulatory complications
0.514 0.486 0.000
E12.4 With neurological complications
0.514 0.486 0.000
E12.3 With ophthalmic complications
0.514 0.486 0.000
E12.2 With renal complications
0.514 0.486 0.000
E12.1 With ketoacidosis
0.514 0.486 0.000
E12.0 With coma
0.514 0.486 0.000
K90.4 Malabsorption due to intolerance, not elsewhere classified
0.513 0.487 0.000
E30.9 Disorder of puberty, unspecified
0.512 0.488 0.000
E30.8 Other disorders of puberty
0.512 0.488 0.000
E30.1 Precocious puberty
0.512 0.488 0.000
E30.0 Delayed puberty
0.512 0.488 0.000
E32.9 Disease of thymus, unspecified
0.512 0.488 0.000
E32.8 Other diseases of thymus
0.512 0.488 0.000
E32.1 Abscess of thymus
0.512 0.488 0.000
E32.0 Persistent hyperplasia of thymus
0.512 0.488 0.000
E35.8 Disorders of other endocrine glands in diseases classified elsewhere
0.512 0.488 0.000
E35.1 Disorders of adrenal glands in diseases classified elsewhere
0.512 0.488 0.000
E35.0 Disorders of thyroid gland in diseases classified elsewhere
0.512 0.488 0.000
E05.2 Thyrotoxicosis with toxic multinodular goitre
0.511 0.489 0.000
E03.8 Other specified hypothyroidism
0.506 0.494 0.000
E34.0 Carcinoid syndrome
0.503 0.497 0.000
C24.0 Extrahepatic bile duct
0.497 0.503 0.000
E21.4 Other specified disorders of parathyroid gland
0.491 0.509 0.000
E21.2 Other hyperparathyroidism
0.491 0.509 0.000
E22 Hyperfunction of pituitary gland
0.486 0.514 0.000
C17.8 Overlapping lesion of small intestine
0.484 0.515 0.000
C17.3 Meckel's diverticulum
0.484 0.515 0.000
C16.8 Overlapping lesion of stomach
0.471 0.529 0.000
C24.9 Biliary tract, unspecified
0.470 0.530 0.000
C16.0 Cardia
0.465 0.535 0.000
E83.4 Disorders of magnesium metabolism
0.005 0.551 0.444
E07.8 Other specified disorders of thyroid
0.447 0.553 0.000
E23.0 Hypopituitarism
0.446 0.553 0.000
C24.8 Overlapping lesion of biliary tract
0.445 0.554 0.000
E21.1 Secondary hyperparathyroidism, not elsewhere classified
0.445 0.555 0.000
K90.8 Other intestinal malabsorption
0.445 0.555 0.000
E06 Thyroiditis
0.442 0.557 0.000
C16.4 Pylorus
0.438 0.562 0.000
E50-E64 Other nutritional deficiencies
0.435 0.565 0.000
C18 Malignant neoplasm of colon
0.435 0.565 0.000
E24.9 Cushing's syndrome, unspecified
0.433 0.567 0.000
C17.1 Jejunum
0.433 0.567 0.000
C18.9 Colon, unspecified
0.431 0.569 0.000
E28.9 Ovarian dysfunction, unspecified
0.418 0.582 0.000
E28.8 Other ovarian dysfunction
0.418 0.582 0.000
E28.1 Androgen excess
0.418 0.582 0.000
E28.0 Oestrogen excess
0.418 0.582 0.000
E28.3 Primary ovarian failure
0.417 0.582 0.000
K90.3 Pancreatic steatorrhoea
0.417 0.583 0.000
K90.2 Blind loop syndrome, not elsewhere classified
0.417 0.583 0.000
K90.1 Tropical sprue
0.417 0.583 0.000
C16.6 Greater curvature of stomach, unspecified
0.415 0.584 0.000
E21.5 Disorder of parathyroid gland, unspecified
0.413 0.587 0.000
E07.1 Dyshormogenetic goitre
0.410 0.589 0.000
E07.0 Hypersecretion of calcitonin
0.410 0.589 0.000
C16.1 Fundus of stomach
0.399 0.601 0.000
E27.8 Other specified disorders of adrenal gland
0.397 0.602 0.001
C17.2 Ileum
0.395 0.605 0.000
C21 Malignant neoplasm of anus and anal canal
0.389 0.611 0.000
C26 Malignant neoplasm of other and ill-defined digestive organs
0.379 0.620 0.001
E26.9 Hyperaldosteronism, unspecified
0.376 0.624 0.001
E26.8 Other hyperaldosteronism
0.376 0.624 0.001
E26.1 Secondary hyperaldosteronism
0.376 0.624 0.001
C16.2 Body of stomach
0.376 0.624 0.000
E21.0 Primary hyperparathyroidism
0.375 0.625 0.000
E44.1 Mild protein-energy malnutrition
0.371 0.629 0.000
E44.0 Moderate protein-energy malnutrition
0.371 0.629 0.000
C16.9 Stomach, unspecified
0.370 0.630 0.000
C18.6 Descending colon
0.359 0.641 0.000
C18.1 Appendix
0.350 0.650 0.000
E22.9 Hyperfunction of pituitary gland, unspecified
0.349 0.651 0.000
E22.8 Other hyperfunction of pituitary gland
0.349 0.651 0.000
E22.1 Hyperprolactinaemia
0.344 0.656 0.000
C16.3 Pyloric antrum
0.336 0.664 0.000
E54 Ascorbic acid deficiency
0.332 0.668 0.000
C17.9 Small intestine, unspecified
0.328 0.671 0.000
E06.5 Other chronic thyroiditis
0.319 0.680 0.000
E06.4 Drug-induced thyroiditis
0.317 0.682 0.000
E06.2 Chronic thyroiditis with transient thyrotoxicosis
0.317 0.682 0.000
E06.1 Subacute thyroiditis
0.317 0.682 0.000
E06.0 Acute thyroiditis
0.317 0.682 0.000
K90.9 Intestinal malabsorption, unspecified
0.316 0.684 0.000
E56 Other vitamin deficiencies
0.313 0.686 0.000
E64 Sequelae of malnutrition and other nutritional deficiencies
0.312 0.688 0.000
E63 Other nutritional deficiencies
0.312 0.688 0.000
E50 Vitamin A deficiency
0.312 0.688 0.000
E60 Dietary zinc deficiency
0.312 0.688 0.000
E59 Dietary selenium deficiency
0.312 0.688 0.000
E52 Niacin deficiency [pellagra]
0.312 0.688 0.000
E51 Thiamine deficiency
0.306 0.693 0.000
Chapter II Neoplasms
0.293 0.707 0.000
C00-C14 Malignant neoplasms of lip, oral cavity and pharynx
0.292 0.708 0.000
E06.9 Thyroiditis, unspecified
0.291 0.709 0.000
C24.1 Ampulla of Vater
0.289 0.711 0.001
E28.2 Polycystic ovarian syndrome
0.287 0.713 0.000
E22.2 Syndrome of inappropriate secretion of antidiuretic hormone
0.284 0.716 0.000
E65-E68 Obesity and other hyperalimentation
0.282 0.718 0.000
E53 Deficiency of other B group vitamins
0.281 0.719 0.000
C21.2 Cloacogenic zone
0.279 0.721 0.000
C18.8 Overlapping lesion of colon
0.275 0.725 0.000
E61 Deficiency of other nutrient elements
0.274 0.726 0.000
E58 Dietary calcium deficiency
0.273 0.727 0.000
C26.8 Overlapping lesion of digestive system
0.272 0.727 0.001
C26.1 Spleen
0.272 0.727 0.001
L40 Psoriasis
0.270 0.730 0.000
C45-C49 Malignant neoplasms of mesothelial and soft tissue
0.268 0.732 0.000
L40.9 Psoriasis, unspecified
0.266 0.734 0.000
C04 Malignant neoplasm of floor of mouth
0.265 0.735 0.000
L40-L45 Papulosquamous disorders
0.265 0.735 0.000
L43.9 Lichen planus, unspecified
0.264 0.736 0.000
D00-D09 In situ neoplasms
0.262 0.738 0.000
L43 Lichen planus
0.262 0.738 0.000
C18.4 Transverse colon
0.261 0.739 0.000
C21.8 Overlapping lesion of rectum, anus and anal canal
0.260 0.740 0.000
C03 Malignant neoplasm of gum
0.258 0.742 0.000
D03 Melanoma in situ
0.256 0.744 0.000
E70-E90 Metabolic disorders
0.251 0.746 0.003
C30-C39 Malignant neoplasms of respiratory and intrathoracic organs
0.251 0.749 0.000
C06 Malignant neoplasm of other and unspecified parts of mouth
0.246 0.754 0.000
D03.5 Melanoma in situ of trunk
0.246 0.754 0.000
E22.0 Acromegaly and pituitary gigantism
0.245 0.754 0.000
D03.6 Melanoma in situ of upper limb, including shoulder
0.243 0.757 0.000
C43-C44 Melanoma and other malignant neoplasms of skin
0.242 0.758 0.000
C13 Malignant neoplasm of hypopharynx
0.242 0.758 0.000
C49 Malignant neoplasm of other connective and soft tissue
0.242 0.758 0.000
C69-C72 Malignant neoplasms of eye, brain and other parts of central nervous system
0.235 0.765 0.000
L53.9 Erythematous condition, unspecified
0.235 0.765 0.000
C02 Malignant neoplasm of other and unspecified parts of tongue
0.233 0.767 0.000
L40.5 Arthropathic psoriasis
0.233 0.767 0.000
C43 Malignant melanoma of skin
0.232 0.768 0.000
C04.9 Floor of mouth, unspecified
0.231 0.769 0.000
C05 Malignant neoplasm of palate
0.227 0.773 0.000
E56.1 Deficiency of vitamin K
0.226 0.774 0.000
E56.9 Vitamin deficiency, unspecified
0.225 0.775 0.000
E56.8 Deficiency of other vitamins
0.225 0.775 0.000
E56.0 Deficiency of vitamin E
0.225 0.775 0.000
L40.3 Pustulosis palmaris et plantaris
0.225 0.775 0.000
E50.9 Vitamin A deficiency, unspecified
0.224 0.776 0.000
E50.8 Other manifestations of vitamin A deficiency
0.224 0.776 0.000
E50.7 Other ocular manifestations of vitamin A deficiency
0.224 0.776 0.000
E50.6 Vitamin A deficiency with xerophthalmic scars of cornea
0.224 0.776 0.000
E50.5 Vitamin A deficiency with night blindness
0.224 0.776 0.000
E50.4 Vitamin A deficiency with keratomalacia
0.224 0.776 0.000
E50.3 Vitamin A deficiency with corneal ulceration and xerosis
0.224 0.776 0.000
E50.2 Vitamin A deficiency with corneal xerosis
0.224 0.776 0.000
E50.1 Vitamin A deficiency with Bitot's spot and conjunctival xerosis
0.224 0.776 0.000
E50.0 Vitamin A deficiency with conjunctival xerosis
0.224 0.776 0.000
E63.9 Nutritional deficiency, unspecified
0.224 0.776 0.000
E63.8 Other specified nutritional deficiencies
0.224 0.776 0.000
E63.1 Imbalance of constituents of food intake
0.224 0.776 0.000
E63.0 Essential fatty acid [EFA] deficiency
0.224 0.776 0.000
E64.9 Sequelae of unspecified nutritional deficiency
0.224 0.776 0.000
E64.8 Sequelae of other nutritional deficiencies
0.224 0.776 0.000
E64.3 Sequelae of rickets
0.224 0.776 0.000
E64.2 Sequelae of vitamin C deficiency
0.224 0.776 0.000
E64.1 Sequelae of vitamin A deficiency
0.224 0.776 0.000
E64.0 Sequelae of protein-energy malnutrition
0.224 0.776 0.000
C07 Malignant neoplasm of parotid gland
0.223 0.777 0.000
C04.0 Anterior floor of mouth
0.223 0.777 0.000
L53 Other erythematous conditions
0.223 0.777 0.000
E84 Cystic fibrosis
0.221 0.778 0.002
D06 Carcinoma in situ of cervix uteri
0.222 0.778 0.000
C43.3 Malignant melanoma of other and unspecified parts of face
0.220 0.779 0.000
C12 Malignant neoplasm of pyriform sinus
0.220 0.780 0.000
E55 Vitamin D deficiency
0.220 0.780 0.000
E51.9 Thiamine deficiency, unspecified
0.220 0.780 0.000
E51.8 Other manifestations of thiamine deficiency
0.220 0.780 0.000
E51.1 Beriberi
0.220 0.780 0.000
C03.9 Gum, unspecified
0.217 0.783 0.000
C32 Malignant neoplasm of larynx
0.217 0.783 0.000
C01 Malignant neoplasm of base of tongue
0.216 0.784 0.000
E78 Disorders of lipoprotein metabolism and other lipidaemias
0.215 0.785 0.000
C08 Malignant neoplasm of other and unspecified major salivary glands
0.214 0.785 0.000
E51.2 Wernicke's encephalopathy
0.214 0.786 0.000
D02 Carcinoma in situ of middle ear and respiratory system
0.214 0.786 0.000
L40.4 Guttate psoriasis
0.214 0.786 0.000
C11 Malignant neoplasm of nasopharynx
0.213 0.786 0.000
C03.1 Lower gum
0.213 0.787 0.000
C38 Malignant neoplasm of heart, mediastinum and pleura
0.213 0.787 0.000
C21.0 Anus, unspecified
0.212 0.787 0.000
L40.0 Psoriasis vulgaris
0.213 0.787 0.000
C49.0 Connective and soft tissue of head, face and neck
0.212 0.788 0.000
C06.0 Cheek mucosa
0.211 0.789 0.000
E88 Other metabolic disorders
0.210 0.789 0.001
C49.3 Connective and soft tissue of thorax
0.210 0.790 0.000
C48 Malignant neoplasm of retroperitoneum and peritoneum
0.209 0.791 0.000
E61.2 Magnesium deficiency
0.208 0.792 0.000
L44 Other papulosquamous disorders
0.207 0.793 0.000
C26.9 Ill-defined sites within the digestive system
0.207 0.793 0.001
C10 Malignant neoplasm of oropharynx
0.207 0.793 0.000
D03.4 Melanoma in situ of scalp and neck
0.207 0.793 0.000
C02.9 Tongue, unspecified
0.206 0.794 0.000
L50-L54 Urticaria and erythema
0.206 0.794 0.000
E73 Lactose intolerance
0.203 0.795 0.002
C32.1 Supraglottis
0.204 0.796 0.000
C09 Malignant neoplasm of tonsil
0.204 0.796 0.000
E75 Disorders of sphingolipid metabolism and other lipid storage disorders
0.201 0.797 0.002
E67 Other hyperalimentation
0.202 0.798 0.000
E68 Sequelae of hyperalimentation
0.202 0.798 0.000
L40.1 Generalised pustular psoriasis
0.202 0.798 0.000
C45 Mesothelioma
0.202 0.798 0.000
C40-C41 Malignant neoplasms of bone and articular cartilage
0.202 0.798 0.000
E53.1 Pyridoxine deficiency
0.201 0.798 0.000
E53.0 Riboflavin deficiency
0.201 0.798 0.000
C97-C97 Malignant neoplasms of independent (primary) multiple sites
0.199 0.801 0.000
C13.9 Hypopharynx, unspecified
0.199 0.801 0.000
D03.2 Melanoma in situ of ear and external auricular canal
0.198 0.802 0.000
C31 Malignant neoplasm of accessory sinuses
0.198 0.802 0.000
E61.9 Deficiency of nutrient element, unspecified
0.197 0.803 0.000
E61.8 Deficiency of other specified nutrient elements
0.197 0.803 0.000
E61.7 Deficiency of multiple nutrient elements
0.197 0.803 0.000
E61.6 Vanadium deficiency
0.197 0.803 0.000
E61.5 Molybdenum deficiency
0.197 0.803 0.000
E61.4 Chromium deficiency
0.197 0.803 0.000
E61.3 Manganese deficiency
0.197 0.803 0.000
E61.0 Copper deficiency
0.197 0.803 0.000
C43.9 Malignant melanoma of skin, unspecified
0.195 0.805 0.000
C43.4 Malignant melanoma of scalp and neck
0.195 0.805 0.000
C05.9 Palate, unspecified
0.194 0.806 0.000
L40.2 Acrodermatitis continua
0.194 0.806 0.000
D03.1 Melanoma in situ of eyelid, including canthus
0.194 0.806 0.000
Chapter XII Diseases of the skin and subcutaneous tissue
0.193 0.807 0.000
C43.5 Malignant melanoma of trunk
0.193 0.807 0.000
C47 Malignant neoplasm of peripheral nerves and autonomic nervous system
0.192 0.807 0.000
C46 Kaposi's sarcoma
0.192 0.807 0.000
C21.1 Anal canal
0.191 0.808 0.000
E84.9 Cystic fibrosis, unspecified
0.191 0.808 0.001
C18.3 Hepatic flexure
0.192 0.808 0.000
C04.8 Overlapping lesion of floor of mouth
0.190 0.810 0.000
C04.1 Lateral floor of mouth
0.190 0.810 0.000
D06.9 Cervix, unspecified
0.190 0.810 0.000
L41 Parapsoriasis
0.190 0.810 0.000
L45 Papulosquamous disorders in diseases classified elsewhere
0.190 0.810 0.000
C71 Malignant neoplasm of brain
0.189 0.811 0.000
E53.9 Vitamin B deficiency, unspecified
0.188 0.811 0.000
L43.3 Subacute (active) lichen planus
0.188 0.812 0.000
L43.2 Lichenoid drug reaction
0.188 0.812 0.000
L43.1 Bullous lichen planus
0.188 0.812 0.000
L43.0 Hypertrophic lichen planus
0.188 0.812 0.000
E26.0 Primary hyperaldosteronism
0.186 0.813 0.001
C18.5 Splenic flexure
0.187 0.813 0.000
C71.1 Frontal lobe
0.187 0.813 0.000
E78.6 Lipoprotein deficiency
0.186 0.813 0.000
C30 Malignant neoplasm of nasal cavity and middle ear
0.186 0.814 0.000
C06.2 Retromolar area
0.186 0.814 0.000
E53.8 Deficiency of other specified B group vitamins
0.186 0.814 0.000
C38.4 Pleura
0.185 0.815 0.000
C13.0 Postcricoid region
0.185 0.815 0.000
E74 Other disorders of carbohydrate metabolism
0.183 0.815 0.002
C03.0 Upper gum
0.185 0.815 0.000
E88.9 Metabolic disorder, unspecified
0.184 0.815 0.001
C00 Malignant neoplasm of lip
0.184 0.816 0.000
D00 Carcinoma in situ of oral cavity, oesophagus and stomach
0.184 0.816 0.000
D03.9 Melanoma in situ, unspecified
0.184 0.816 0.000
D03.0 Melanoma in situ of lip
0.184 0.816 0.000
L53.0 Toxic erythema
0.184 0.816 0.000
D03.8 Melanoma in situ of other sites
0.183 0.817 0.000
C33 Malignant neoplasm of trachea
0.183 0.817 0.000
E77 Disorders of glycoprotein metabolism
0.180 0.817 0.002
E76 Disorders of glycosaminoglycan metabolism
0.180 0.817 0.002
E72 Other disorders of amino-acid metabolism
0.180 0.817 0.002
E71 Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism
0.180 0.817 0.002
E70 Disorders of aromatic amino-acid metabolism
0.180 0.817 0.002
E90 Nutritional and metabolic disorders in diseases classified elsewhere
0.180 0.817 0.002
C49.6 Connective and soft tissue of trunk, unspecified
0.181 0.819 0.000
C73-C75 Malignant neoplasms of thyroid and other endocrine glands
0.180 0.819 0.000
C39 Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs
0.180 0.820 0.000
C37 Malignant neoplasm of thymus
0.180 0.820 0.000
C69 Malignant neoplasm of eye and adnexa
0.180 0.820 0.000
C49.9 Connective and soft tissue, unspecified
0.180 0.820 0.000
D01 Carcinoma in situ of other and unspecified digestive organs
0.180 0.820 0.000
E78.1 Pure hyperglyceridaemia
0.179 0.821 0.000
D02.0 Larynx
0.179 0.821 0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue
0.179 0.821 0.000
L52 Erythema nodosum
0.178 0.822 0.000
E78.9 Disorder of lipoprotein metabolism, unspecified
0.177 0.823 0.000
E07.9 Disorder of thyroid, unspecified
0.177 0.823 0.000
C06.8 Overlapping lesion of other and unspecified parts of mouth
0.177 0.823 0.000
C06.1 Vestibule of mouth
0.177 0.823 0.000
E84.0 Cystic fibrosis with pulmonary manifestations
0.175 0.824 0.001
C70 Malignant neoplasm of meninges
0.175 0.824 0.000
C13.8 Overlapping lesion of hypopharynx
0.174 0.826 0.000
C13.2 Posterior wall of hypopharynx
0.174 0.826 0.000
C13.1 Aryepiglottic fold, hypopharyngeal aspect
0.174 0.826 0.000
C49.8 Overlapping lesion of connective and soft tissue
0.173 0.827 0.000
C49.4 Connective and soft tissue of abdomen
0.173 0.827 0.000
E78.5 Hyperlipidaemia, unspecified
0.173 0.827 0.000
C02.2 Ventral surface of tongue
0.171 0.829 0.000
C06.9 Mouth, unspecified
0.170 0.830 0.000
E73.9 Lactose intolerance, unspecified
0.168 0.831 0.001
L53.8 Other specified erythematous conditions
0.169 0.831 0.000
L10-L14 Bullous disorders
0.169 0.831 0.000
C14 Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx
0.168 0.832 0.000
C02.8 Overlapping lesion of tongue
0.167 0.832 0.000
C02.3 Anterior two-thirds of tongue, part unspecified
0.167 0.832 0.000
C02.0 Dorsal surface of tongue
0.167 0.832 0.000
C84 Peripheral and cutaneous T-cell lymphomas
0.167 0.833 0.000
D09 Carcinoma in situ of other and unspecified sites
0.167 0.833 0.000
C43.1 Malignant melanoma of eyelid, including canthus
0.167 0.833 0.000
L44.0 Pityriasis rubra pilaris
0.166 0.833 0.000
C43.8 Overlapping malignant melanoma of skin
0.166 0.834 0.000
C43.0 Malignant melanoma of lip
0.166 0.834 0.000
E75.5 Other lipid storage disorders
0.165 0.834 0.001
D06.0 Endocervix
0.166 0.834 0.000
C49.5 Connective and soft tissue of pelvis
0.166 0.834 0.000
C48.0 Retroperitoneum
0.165 0.835 0.000
E78.4 Other hyperlipidaemia
0.164 0.836 0.000
C05.8 Overlapping lesion of palate
0.163 0.837 0.000
C05.2 Uvula
0.163 0.837 0.000
C05.0 Hard palate
0.163 0.837 0.000
L42 Pityriasis rosea
0.162 0.838 0.000
E79 Disorders of purine and pyrimidine metabolism
0.159 0.838 0.003

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.